Analysis of Geographic Areas
Regeneron Pharmaceuticals Inc. operates in 2 regions: United States and Rest of world.
Area Asset Turnover
Regeneron Pharmaceuticals Inc., asset turnover by geographic area
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 2.00 | 2.30 | 4.51 | 2.32 | 2.28 |
| Rest of world | 0.42 | 0.09 | 0.00 | 0.00 | 0.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
| Rest of world | Rest of world area asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023. |
Area Asset Turnover: United States
Regeneron Pharmaceuticals Inc.; United States; area asset turnover calculation
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Net product sales | 6,753,700) | 6,820,700) | 12,117,200) | 5,567,600) | 4,834,400) |
| Net property, plant, and equipment | 3,375,000) | 2,960,000) | 2,684,400) | 2,397,800) | 2,117,600) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 2.00 | 2.30 | 4.51 | 2.32 | 2.28 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Area asset turnover = Net product sales ÷ Net property, plant, and equipment
= 6,753,700 ÷ 3,375,000 = 2.00
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | United States | United States area asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023. |
Area Asset Turnover: Rest of world
Regeneron Pharmaceuticals Inc.; Rest of world; area asset turnover calculation
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||
| Net product sales | 324,300) | 73,000) | —) | —) | —) |
| Net property, plant, and equipment | 771,400) | 803,000) | 797,800) | 823,800) | 772,800) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 0.42 | 0.09 | 0.00 | 0.00 | 0.00 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Area asset turnover = Net product sales ÷ Net property, plant, and equipment
= 324,300 ÷ 771,400 = 0.42
| Area activity ratio | Geographic area | The company |
|---|---|---|
| Area asset turnover | Rest of world | Rest of world area asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023. |
Net product sales
Regeneron Pharmaceuticals Inc., net product sales by geographic area
US$ in thousands
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 6,753,700) | 6,820,700) | 12,117,200) | 5,567,600) | 4,834,400) |
| Rest of world | 324,300) | 73,000) | —) | —) | —) |
| Total | 7,078,000) | 6,893,700) | 12,117,200) | 5,567,600) | 4,834,400) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Net property, plant, and equipment
Regeneron Pharmaceuticals Inc., net property, plant, and equipment by geographic area
US$ in thousands
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| United States | 3,375,000) | 2,960,000) | 2,684,400) | 2,397,800) | 2,117,600) |
| Rest of world | 771,400) | 803,000) | 797,800) | 823,800) | 772,800) |
| Total | 4,146,400) | 3,763,000) | 3,482,200) | 3,221,600) | 2,890,400) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).